Decitabine enclosed biotin-zein conjugated nanoparticles: synthesis, characterization, in vitro and in vivo evaluation.

Nanomedicine (London, England) Pub Date : 2024-01-01 Epub Date: 2024-07-23 DOI:10.1080/17435889.2024.2374700
Akshada Mhaske, Jasleen Kaur, Saba Naqvi, Rahul Shukla
{"title":"Decitabine enclosed biotin-zein conjugated nanoparticles: synthesis, characterization, <i>in vitro</i> and <i>in vivo</i> evaluation.","authors":"Akshada Mhaske, Jasleen Kaur, Saba Naqvi, Rahul Shukla","doi":"10.1080/17435889.2024.2374700","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> This study focuses on biotinylated nanocarriers designed to encapsulate amphiphilic molecules with self-biodegradable properties for enhanced drug delivery.<b>Methods:</b> Biotin-zein conjugated nanoparticles were synthesized and tested in C6 cell lines to evaluate their viability and cellular uptake. Optimization was achieved using a a central composite design. The nanoparticles underwent thermogravimetric analysis, and their pharmacokinetics and biodistribution were also studied.<b>Results:</b> The optimized nanoparticles displayed 96.31% drug encapsulation efficiency, a particle size of 95.29 nm and a zeta potential of -17.7 mV. These nanoparticles showed increased cytotoxicity and improved cellular uptake compared with free drugs. Thermogravimetric analysis revealed that the drug-loaded nanocarriers provided better protection against drug degradation. Pharmacokinetic and biodistribution studies indicated that the formulation had an extended brain residence time, highlighting its effectiveness.<b>Conclusion:</b> The biotin-zein conjugated nanoparticles developed in this study offer a promising nano-vehicle for <i>in vivo</i> biodistribution and pharmacokinetic applications. Their high drug encapsulation efficiency, stability and extended brain residence time suggest they are effective for targeted drug delivery and therapeutic uses.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418219/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17435889.2024.2374700","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/23 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: This study focuses on biotinylated nanocarriers designed to encapsulate amphiphilic molecules with self-biodegradable properties for enhanced drug delivery.Methods: Biotin-zein conjugated nanoparticles were synthesized and tested in C6 cell lines to evaluate their viability and cellular uptake. Optimization was achieved using a a central composite design. The nanoparticles underwent thermogravimetric analysis, and their pharmacokinetics and biodistribution were also studied.Results: The optimized nanoparticles displayed 96.31% drug encapsulation efficiency, a particle size of 95.29 nm and a zeta potential of -17.7 mV. These nanoparticles showed increased cytotoxicity and improved cellular uptake compared with free drugs. Thermogravimetric analysis revealed that the drug-loaded nanocarriers provided better protection against drug degradation. Pharmacokinetic and biodistribution studies indicated that the formulation had an extended brain residence time, highlighting its effectiveness.Conclusion: The biotin-zein conjugated nanoparticles developed in this study offer a promising nano-vehicle for in vivo biodistribution and pharmacokinetic applications. Their high drug encapsulation efficiency, stability and extended brain residence time suggest they are effective for targeted drug delivery and therapeutic uses.

地西他滨封闭生物素-zein共轭纳米颗粒:合成、表征、体外和体内评价。
目的:本研究的重点是设计生物素化纳米载体,以封装具有自生物降解特性的两亲性分子,从而增强药物输送。研究方法合成了生物素-zein共轭纳米颗粒,并在C6细胞系中进行了测试,以评估其活力和细胞吸收。采用中心复合设计进行了优化。对纳米颗粒进行了热重分析,并研究了它们的药代动力学和生物分布。研究结果优化后的纳米颗粒药物包封效率为 96.31%,粒径为 95.29 nm,zeta 电位为 -17.7 mV。与游离药物相比,这些纳米颗粒显示出更强的细胞毒性和更高的细胞吸收率。热重分析表明,载药纳米载体能更好地防止药物降解。药代动力学和生物分布研究表明,该制剂在大脑中的停留时间较长,突出了其有效性。结论本研究开发的生物素-zein 共轭纳米颗粒是一种很有前景的纳米载体,可用于体内生物分布和药代动力学应用。它们的药物包封效率高、稳定性好、脑滞留时间长,这表明它们能有效地用于靶向给药和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信